MX9702731A - Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos. - Google Patents
Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos.Info
- Publication number
- MX9702731A MX9702731A MX9702731A MX9702731A MX9702731A MX 9702731 A MX9702731 A MX 9702731A MX 9702731 A MX9702731 A MX 9702731A MX 9702731 A MX9702731 A MX 9702731A MX 9702731 A MX9702731 A MX 9702731A
- Authority
- MX
- Mexico
- Prior art keywords
- ltb4
- compounds
- antagonists
- benzo
- leukotriene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32287694A | 1994-10-13 | 1994-10-13 | |
| PCT/IB1995/000401 WO1996011920A1 (en) | 1994-10-13 | 1995-05-26 | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists |
| US322876 | 1999-05-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MXPA97002731A MXPA97002731A (en) | 1997-06-01 |
| MX9702731A true MX9702731A (es) | 1997-06-28 |
Family
ID=23256829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9702731A MX9702731A (es) | 1994-10-13 | 1995-05-26 | Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos. |
Country Status (23)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2265043C (en) * | 1996-09-16 | 2003-01-14 | Pfizer Inc. | Processes and intermediates for preparing substituted chromanol derivatives |
| JP2001509143A (ja) * | 1996-12-13 | 2001-07-10 | イーライ・リリー・アンド・カンパニー | 大脳病巣性卒中のためのロイコトリエンアンタゴニスト |
| IL128731A0 (en) * | 1998-03-12 | 2000-01-31 | Pfizer Prod Inc | Method of preventing allograft rejection |
| EP0963755A3 (en) * | 1998-04-16 | 2001-03-14 | Pfizer Products Inc. | Use of benzopyranes for preventing allograft rejection |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| BR0206771A (pt) * | 2001-01-30 | 2004-02-25 | Pfizer Prod Inc | Processos para a preparação de cidos cromanilbenzóicos |
| AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
| AU2003243089B2 (en) | 2002-06-19 | 2010-01-07 | Biovitrum Ab (Publ) | Novel compounds, their use and preparation |
| EP1773396A1 (en) * | 2004-07-22 | 2007-04-18 | Pharmacia Corporation | Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
| US7576094B2 (en) * | 2004-12-13 | 2009-08-18 | Eli Lilly And Company | Spiro derivatives as lipoxygenase inhibitors |
| US20080207588A1 (en) | 2005-02-25 | 2008-08-28 | Chu Daniel T W | Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines |
| US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
| CA2651942A1 (en) | 2006-05-11 | 2008-07-03 | Janssen Pharmaceutica N.V. | 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| US7749995B2 (en) * | 2006-05-11 | 2010-07-06 | Janssen Pharmaceutica Nv | 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors |
| KR101258331B1 (ko) | 2008-09-11 | 2013-04-26 | 화이자 인코포레이티드 | 헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도 |
| PE20120668A1 (es) | 2009-03-11 | 2012-06-01 | Pfizer | Un compuesto n,n-dimetil-5-(2-metil-6-((5-metilpirazin-2-il)carbamoil)benzofuran-4-iloxi)pirimidin-carboxamida como activador de glucocinasa |
| EP2814494B1 (en) | 2012-02-14 | 2019-08-21 | Children's Hospital Medical Center | Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox) |
| CN102920692A (zh) * | 2012-10-25 | 2013-02-13 | 中国人民解放军第二军医大学 | (e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用 |
| CA2979391C (en) | 2015-03-13 | 2023-10-17 | Forma Therapeutics, Inc. | Alpha-cinnamide compounds and compositions as hdac8 inhibitors |
| WO2017040963A1 (en) | 2015-09-03 | 2017-03-09 | Forma Therapeutics, Inc. | [6,6] fused bicyclic hdac8 inhibitors |
| WO2017095722A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| US10450309B2 (en) | 2015-11-30 | 2019-10-22 | Merch Sharp & Dohme Corp. | Aryl sulfonamides as BLT1 antagonists |
| WO2017095723A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl acylsulfonamides as blt1 antagonists |
| WO2017095724A1 (en) | 2015-11-30 | 2017-06-08 | Merck Sharp & Dohme Corp. | Aryl sulfonamides as blt1 antagonists |
| WO2018071687A1 (en) * | 2016-10-13 | 2018-04-19 | The Regents Of The University Of California | Methods of treating pruritis |
| CN119700747B (zh) * | 2025-02-26 | 2025-05-06 | 云南农业大学 | 苦杏碱醇a在制备防治骨质疏松症产品中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU469247A3 (ru) * | 1972-01-14 | 1975-04-30 | Майлз Лабораториз Инк (Фирма) | Способ получени производных хромона |
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| CA1320490C (en) * | 1987-01-12 | 1993-07-20 | Darrel M. Gapinski | Anti-inflammatory agents |
| US4889871A (en) * | 1987-05-29 | 1989-12-26 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| CA2019335C (en) * | 1989-06-27 | 2000-08-01 | Mitoshi Konno | Phenylalkan (en)oic acids |
| US4996230A (en) * | 1990-02-16 | 1991-02-26 | Eli Lilly And Company | Leukotriene antagonists |
| US5073562A (en) * | 1990-05-10 | 1991-12-17 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
| US5051438A (en) * | 1990-05-16 | 1991-09-24 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use |
| US5124350A (en) * | 1990-06-28 | 1992-06-23 | G. D. Searle & Co. | Leukotriene b4 antagonists |
| MX9300312A (es) * | 1992-01-23 | 1993-07-31 | Pfizer | Antagonistas benzopiranicos y relacionado de ltb. |
| ES2098547T3 (es) * | 1992-01-23 | 1997-05-01 | Pfizer | Benzopirano y otros antagonistas de ltb4 relacionados. |
-
1995
- 1995-05-26 WO PCT/IB1995/000401 patent/WO1996011920A1/en not_active Application Discontinuation
- 1995-05-26 CA CA002201742A patent/CA2201742A1/en not_active Abandoned
- 1995-05-26 RU RU97105834A patent/RU2128655C1/ru active
- 1995-05-26 CZ CZ971117A patent/CZ111797A3/cs unknown
- 1995-05-26 HU HU9702048A patent/HUT77515A/hu unknown
- 1995-05-26 NZ NZ285156A patent/NZ285156A/xx unknown
- 1995-05-26 KR KR1019970702392A patent/KR100232341B1/ko not_active Expired - Fee Related
- 1995-05-26 EP EP95918114A patent/EP0785930A1/en not_active Withdrawn
- 1995-05-26 US US08/809,728 patent/US6051601A/en not_active Expired - Fee Related
- 1995-05-26 CN CN95195608A patent/CN1160399A/zh active Pending
- 1995-05-26 JP JP8513057A patent/JP2983295B2/ja not_active Expired - Lifetime
- 1995-05-26 AU AU24167/95A patent/AU696890B2/en not_active Ceased
- 1995-05-26 MX MX9702731A patent/MX9702731A/es unknown
- 1995-05-26 PL PL95319688A patent/PL319688A1/xx unknown
- 1995-10-04 CO CO95046243A patent/CO4480024A1/es unknown
- 1995-10-06 IL IL11552995A patent/IL115529A0/xx unknown
- 1995-10-10 PE PE1995281391A patent/PE10897A1/es not_active Application Discontinuation
- 1995-10-11 BR BR9504385A patent/BR9504385A/pt not_active Application Discontinuation
- 1995-10-12 ZA ZA958597A patent/ZA958597B/xx unknown
- 1995-10-13 TR TR95/01270A patent/TR199501270A2/xx unknown
- 1995-10-13 TW TW084110874A patent/TW304941B/zh active
-
1997
- 1997-04-11 NO NO971672A patent/NO971672L/no not_active Application Discontinuation
- 1997-04-11 FI FI971524A patent/FI971524A7/fi unknown
-
2000
- 2000-01-28 US US09/493,707 patent/US6133286A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996011920A1 (en) | 1996-04-25 |
| NO971672L (no) | 1997-06-11 |
| CZ111797A3 (cs) | 1998-07-15 |
| CO4480024A1 (es) | 1997-07-09 |
| KR970706270A (ko) | 1997-11-03 |
| BR9504385A (pt) | 1997-05-27 |
| CA2201742A1 (en) | 1996-04-25 |
| JP2983295B2 (ja) | 1999-11-29 |
| IL115529A0 (en) | 1996-01-19 |
| EP0785930A1 (en) | 1997-07-30 |
| NO971672D0 (no) | 1997-04-11 |
| HUT77515A (hu) | 1998-05-28 |
| TR199501270A2 (tr) | 1996-06-21 |
| PL319688A1 (en) | 1997-08-18 |
| JPH09512035A (ja) | 1997-12-02 |
| ZA958597B (en) | 1997-04-14 |
| CN1160399A (zh) | 1997-09-24 |
| AU2416795A (en) | 1996-05-06 |
| US6133286A (en) | 2000-10-17 |
| RU2128655C1 (ru) | 1999-04-10 |
| KR100232341B1 (ko) | 2000-07-01 |
| PE10897A1 (es) | 1997-04-21 |
| NZ285156A (en) | 1999-01-28 |
| AU696890B2 (en) | 1998-09-24 |
| US6051601A (en) | 2000-04-18 |
| FI971524A0 (fi) | 1997-04-11 |
| TW304941B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1997-05-11 |
| FI971524A7 (fi) | 1997-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9702731A (es) | Compuestos de benzopirano y benzo fusionados, composiciones que los contienen y uso de los mismos. | |
| Gunatilaka et al. | Biological activity of some coumarins from Sri Lankan Rutaceae | |
| GT200100014A (es) | Compuestos de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo. | |
| AR019692A1 (es) | INHIBIDORES DE FACTOR DE TRANSCRIPCION NF-kB. | |
| ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
| UY26025A1 (es) | Procedimiento para la preparacion de composiciones de celecoxib | |
| AR013001A1 (es) | Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina. | |
| AR012653A1 (es) | UNA COMPOSICIoN NUTRICIONAL QUE COMPRENDE EXTRACTO DE PLANTA PARA EL TRATAMIENTO DE RESORCIoN oSEA INCREMENTADA Y EL USO LA MISMA PARA LA PREPARACIoN DE UN MEDICAMENTO. | |
| ES2181614T3 (es) | Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa. | |
| ECSP055531A (es) | "nuevos derivados de glicósido de tiofeno, metodos para la preparacion de los mismos, medicamentos que comprenden dichos compuestos, y su uso" | |
| ES2058306T3 (es) | Tetralinas substituidas, cromanos y compuestos relacionados en el tratamiento del asma, artritis y enfermedades relacionadas. | |
| CO4290424A1 (es) | Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina | |
| UY27199A1 (es) | Nuevos compuestos antiinflamatorios de triazolopiridinas | |
| MX9306271A (es) | Carbamatos de rapamicina y composicion farmaceutica que los incluye. | |
| BR0113286B1 (pt) | pirazàis substituÍdos e composiÇço farmacÊutica compreendendo os mesmos. | |
| GT199900140A (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos. | |
| MX9700890A (es) | 1, 4-benzotiazepina-1, 1-dioxidos hipolipidemicos. | |
| GT199800083A (es) | Agonistas de prostaglandinas. | |
| PA8508201A1 (es) | Derivados de heterociclo-alquilsulfonil pirazolo como agentes anti-inflamatorios/analgesicos | |
| ES2172695T3 (es) | Carboxamidas y sulfonamidas de benzofurano. | |
| YU33298A (en) | Pharmaceutical formulation useful for the treatment of asthma allergies and inflammations | |
| AR004480A1 (es) | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen | |
| MX9307608A (es) | Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen. | |
| ES2109229T3 (es) | Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas. | |
| AR002704A1 (es) | 2-(2-n-alcoxifenil)-purin-6-onas 9-sustituidas, procedimiento para su preparacion, composiciones farmaceuticas que las contienen y su uso parapreparar composiciones farmaceuticas. |